NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 72 filers reported holding NEXTCURE INC in Q4 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $336,000 | -51.0% | 71,435 | -49.4% | 0.06% | -32.2% |
| Q1 2022 | $686,000 | -14.7% | 141,058 | +5.2% | 0.09% | -25.0% |
| Q4 2021 | $804,000 | -76.6% | 134,055 | -73.7% | 0.12% | -50.4% |
| Q3 2021 | $3,431,000 | -17.3% | 509,155 | -1.5% | 0.24% | -28.0% |
| Q2 2021 | $4,151,000 | -8.6% | 516,870 | +13.9% | 0.34% | +119.6% |
| Q1 2021 | $4,544,000 | +108.5% | 453,952 | +127.0% | 0.15% | +59.4% |
| Q4 2020 | $2,179,000 | +23.8% | 200,000 | 0.0% | 0.10% | -24.4% |
| Q3 2020 | $1,760,000 | +16.6% | 200,000 | +391.4% | 0.13% | +12.4% |
| Q1 2020 | $1,509,000 | – | 40,700 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 721,302 | $4,862,000 | 2.75% |
| Sofinnova Investments, Inc. | 2,671,856 | $18,008,000 | 1.07% |
| Canaan Partners X LLC | 321,647 | $2,168,000 | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $2,022,000 | 0.42% |
| Diametric Capital, LP | 76,162 | $513,000 | 0.40% |
| Lion Point Capital, LP | 300,000 | $2,022,000 | 0.38% |
| DAFNA Capital Management LLC | 183,491 | $1,237,000 | 0.33% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 217,139 | $1,464,000 | 0.25% |
| Ikarian Capital, LLC | 509,155 | $3,431,000 | 0.24% |
| Orbimed Advisors | 2,711,013 | $18,272,000 | 0.20% |